Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
ViiV Healthcare, a leading HIV company owned by GSK and Shionogi, revealed over $33 million in community grants for the U.S. in 2026. This funding will aid 230 organizations in 110 cities across 36 states and territories, including Puerto Rico. The grants aim to assist populations most affected by HIV, providing crucial support services.
